Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,049 DKK | -0.81% | +3.88% | -21.11% |
03-27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
5.4M | - | - | - | - | - | |
115B | ||||||
106B | ||||||
21.84B | - | |||||
21.96B | - | |||||
19.21B |
- Stock Market
- Equities
- ORPHA Stock
- Charts Orphazyme A/S
- Sector Chart